NCT02400970|Unknown
Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors
TESTIMAR
Study About Contamination of Testicle Tissue by RT-PCR in Children With Solid Tumors
Loading search results
TESTIMAR
Study About Contamination of Testicle Tissue by RT-PCR in Children With Solid Tumors
Sponsor study identifier
observational
40
1 country
1
Study Start
November 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
For prepubertal patients, cryopreservation of testicular tissue is the only option available to preserve their fertility before cancer treatment. But testicular autograft raises the issue of the risk of reintroduction of potentially malignant cells. The aim of our study is to develop a specific and sensitive method for residual disease detection in the testicular tissue from patients treated for a solid tumor during infancy, whose fertility may have been compromised by treatments and who benefited of testicular tissue cryopreservation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2014
Date type not reportedThis date has not been verified as actual or estimated.
March 24, 2015
Actual (reported)March 27, 2015
Actual (reported)November 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
malignant cells about 1/10 *6 cells.
at day 1
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patients treated for a solid tumor during infancy
Contact the study team to confirm eligibility.
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
Chaput L, Greze V, Halle P, Radosevic-Robin N, Pereira B, Veronese L, Lejeune H, Durand P, Martin G, Sanfilippo S, Canis M, Kanold J, Tchirkov A, Brugnon F. Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model. Cancers (Basel). 2019 Nov 17;11(11):1807. doi: 10.3390/cancers11111807.
Justyna KANOLD
University Hospital, Clermont-Ferrand
First Submitted
March 24, 2015
First Posted
March 27, 2015
Study Start
November 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Oocyte Cryopreservation
Study Completion
June 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 27, 2015
Record last verified: 2015-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: